NCT04122833View on ClinicalTrials.gov

Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study

UnknownOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

September 30, 2023

Study Completion Date

December 31, 2024

Conditions
Adenocarcinoma of LungEGFR Activating Mutation
Interventions
OTHER

Next generation sequencing

observational study

Trial Locations (2)

05505

RECRUITING

Asan medical center, Seoul

Unknown

NOT_YET_RECRUITING

Catholic university medical center, Seoul St. Mary's Hospital, Seoul

Sponsors

Collaborators (1)

Foundation Medicine
All Listed Sponsors
collaborator

Roche Diagnostics GmbH

INDUSTRY

collaborator

Foundation Medicine

INDUSTRY

lead

Konkuk University Medical Center

OTHER

NCT04122833 - Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study | Biotech Hunter | Biotech Hunter